Location History:
- Medford, MA (US) (2018 - 2021)
- Somerville, MA (US) (2021)
- Belmont, MA (US) (2022 - 2024)
Company Filing History:
Years Active: 2018-2025
Title: Innovations and Contributions of Jeffrey Groom, II in the Field of Medical Embolization
Introduction: Jeffrey Groom, II, based in Belmont, MA, is an accomplished inventor with a remarkable portfolio of 18 patents. His work primarily focuses on advanced embolic compositions and methods, contributing significantly to the medical and biomedical fields.
Latest Patents: Among his latest patents are two noteworthy innovations related to embolic compositions. The disclosures pertain to crosslinkable compositions and systems, as well as methods for forming crosslinked compositions in situ. These innovations are particularly relevant for embolizing vasculature, including the neurovasculature within patients. His work reflects a commitment to improving medical procedures and enhancing patient outcomes.
Career Highlights: Jeffrey has made notable contributions to the field of biomedical innovations through his work with respected companies such as Arsenal Medical, Inc. and Medtronic Vascular, Inc. His expertise in the development of medical technologies has positioned him as a leader in his domain, pushing the boundaries of what is possible in medical treatments.
Collaborations: Throughout his career, Jeffrey has had the opportunity to collaborate with skilled professionals, including Craig Wiltsey and Nikhita Mansukhani. These collaborations have not only augmented his work but have also fostered innovative ideas and breakthroughs in medical technology.
Conclusion: Jeffrey Groom, II has left an indelible mark in the realm of medical inventions with his 18 patents and expertise in embolic compositions. His contributions to companies like Arsenal Medical and Medtronic Vascular showcase the importance of innovation in healthcare. As he continues to advance his research and innovations, the impact of his work will undoubtedly benefit the medical community and patients alike.